Certain glucose-lowering meds associated with lower risk for COPD exacerbations
For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...
The Hospitalist1d
Gabapentinoid Use Associated with Increased Risk of Severe Exacerbations in Patientswith COPD
Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...
BMJ2d
Real-world evidence is a vital tool for informing treatment strategies in chronic obstructive pulmonary disease
The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...
Managed Healthcare Executive2d
Trelegy and Breo Offer Incremental Improvement Over Generics
The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...
copdnewstoday9d
Healthy at Home feasible, effective for mobile COPD care: Pilot study
The digital Healthy at Home intervention appeared to improve quality of life for patients and decreased COPD-related distress ...
Monthly Prescribing Reference9d
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
Researchers found that the risk for moderate or severe COPD exacerbation was ... aged 40 years or older with T2D and active COPD who initiated treatment with SGLT-2is vs DPP-4is; GLP-1 RAs vs ...